Aura Biosciences (AURA) Profit After Tax (2020 - 2026)
Aura Biosciences (AURA) posted Profit After Tax of -$33.7 million for Q1 2026, down 29.94% on a QoQ basis from -$25.9 million in Q4 2025, and down 22.57% year-over-year from -$43.5 million in Q1 2025.
Aura Biosciences (AURA) Profit After Tax (2020 - 2026) Analysis & Trends
Aura Biosciences' Profit After Tax history runs 7 years deep, the most recent figure standing at -$33.7 million for Q1 2026.
- Quarterly Profit After Tax fell 22.57% year-over-year to -$33.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$112.7 million (down 54.11% YoY) and the FY2025 annual result came in at -$106.6 million, down 22.2% from the prior year.
- Profit After Tax was -$33.7 million for Q1 2026 at Aura Biosciences, down from -$25.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at $790000.0 in Q3 2024 and bottomed at -$33.7 million in Q1 2026.
- A 5-year average of -$18.9 million and a median of -$19.7 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax soared 787.64% — and 2025, when it tumbled 3402.03%.
- Aura Biosciences' Profit After Tax stood at -$16.4 million in 2022, then sank by 34.85% to -$22.1 million in 2023, then retreated by 17.98% to -$26.1 million in 2024, then grew by 0.71% to -$25.9 million in 2025, then dropped by 29.94% to -$33.7 million in 2026.
- Business Quant data shows AURA's Profit After Tax at -$33.7 million in Q1 2026, -$25.9 million in Q4 2025, and -$26.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -33.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.69 Mn |
| Dec 31, 2025 | -25.92 Mn |
| Sep 30, 2025 | -26.09 Mn |
| Jun 30, 2025 | -27.02 Mn |
| Mar 31, 2025 | -27.48 Mn |
| Dec 31, 2024 | -26.11 Mn |
| Sep 30, 2024 | 790,000.00 |
| Jun 30, 2024 | -20.34 Mn |
| Mar 31, 2024 | -19.71 Mn |
| Dec 31, 2023 | -22.13 Mn |
| Sep 30, 2023 | 89,000.00 |
| Jun 30, 2023 | -18.30 Mn |
| Mar 31, 2023 | -17.47 Mn |
| Dec 31, 2022 | -16.41 Mn |
| Sep 30, 2022 | -15.90 Mn |
| Jun 30, 2022 | -13.47 Mn |
| Mar 31, 2022 | -12.84 Mn |
| Dec 31, 2021 | -11.68 Mn |
| Sep 30, 2021 | -8.84 Mn |
| Jun 30, 2021 | -8.85 Mn |